Phase
Condition
Williams Syndrome
High Blood Pressure (Hypertension - Pediatric)
Circulation Disorders
Treatment
N/AClinical Study ID
Ages > 20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Satisfy office msSBP ≥180 mmHg or office msDBP ≥110 mmHg at baseline
Exclusion
Exclusion Criteria:
Patients show msSBP ≥220 mmHg and/or msDBP ≥120 mmHg
History of angioedema, drug-related or otherwise, as reported by the patient
Patients unwilling or not able to discontinue safely the use of currentantihypertensive medications during the study, as required by the protocol.
Patients have significant cardiovascular co-morbidities
Patients who previously entered a LCZ696 study and had been randomized or enrolledinto the active drug treatment epoch. Other protocol defined inclusion/exclusion criteria may apply.
Study Design
Study Description
Connect with a study center
Novartis Investigative Site
Yokohama, Kanagawa 231-0023
JapanSite Not Available
Novartis Investigative Site
Yokohama-city, Kanagawa 231-0023
JapanSite Not Available
Novartis Investigative Site
Kyoto-city, Kyoto 606-8507
JapanSite Not Available
Novartis Investigative Site
Bunkyo-ku, Tokyo 113-0031
JapanSite Not Available
Novartis Investigative Site
Hachioji-city, Tokyo 192-0918
JapanSite Not Available
Novartis Investigative Site
Minato-ku, Tokyo 108-0075
JapanSite Not Available
Novartis Investigative Site
Ota-ku, Tokyo 143-0023
JapanSite Not Available
Novartis Investigative Site
Shibuya-ku, Tokyo 150-0002
JapanSite Not Available
Novartis Investigative Site
Shinagawa-ku, Tokyo 141-0032
JapanSite Not Available
Novartis Investigative Site
Kyoto, 606-8507
JapanSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.